TY - JOUR
T1 - Factors associated with the receipt and completion of whole brain radiation therapy among older adults in the United States from 2010-2013
AU - Ghiassi-Nejad, Zahra
AU - Sindhu, Kunal K.
AU - Moshier, Erin
AU - Zubizarreta, Nicole
AU - Mazumdar, Madhu
AU - Goldstein, Nathan E.
AU - Dharmarajan, Kavita V.
N1 - Funding Information:
This work was supported by a pilot award from the National Institute on Aging Claude D. Pepper Older Americans Independence Center under Grant # 5P30AG028741 awarded to Kavita V. Dharmarajan. The authors also wish to acknowledge the support of Biostatics Shared Resource Facility , Icahn School of Medicine , and NCI Cancer Center Support Grant # P30CA196521-01 . The authors have no financial disclosures or conflicts to report. The authors do not have any proprietary interests in the materials described in the article. This work has not been previously presented.
Funding Information:
This work was supported by a pilot award from the National Institute on Aging Claude D. Pepper Older Americans Independence Center under Grant #5P30AG028741 awarded to Kavita V. Dharmarajan. The authors also wish to acknowledge the support of Biostatics Shared Resource Facility, Icahn School of Medicine, and NCI Cancer Center Support Grant #P30CA196521-01. The authors have no financial disclosures or conflicts to report. The authors do not have any proprietary interests in the materials described in the article. This work has not been previously presented.
Publisher Copyright:
© 2020
PY - 2020/9
Y1 - 2020/9
N2 - Introduction: Whole brain radiation therapy (WBRT) is widely used to treat patients with brain metastases. However, there is debate regarding its utility in patients with poor prognoses. In this study, we sought to characterize the use of WBRT in the United States, especially in adults aged 55 and above. Material and Methods: Patients with brain metastases were identified using the National Cancer Database between 2010 and 2013. The receipt and completion of WBRT with various patient factors were correlated using multivariable logistic regression. Results: 28,422 patients with brain metastases were identified, 23,362 of whom were aged 55 or above. 14,845 patients received WBRT and 12,310 patients completed treatment. Among adults aged 55 and above, 11,945 patients received WBRT, and 9812 patients completed treatment. Patients aged 60 and above were less likely to receive WBRT, while those aged 65 and above were less likely to complete WBRT. Discussion: These results suggest that WBRT may be over-utilized in the United States, especially among older adults. Better interventions to improve pre-WBRT decision-making in this population are needed to select patients who might derive benefit.
AB - Introduction: Whole brain radiation therapy (WBRT) is widely used to treat patients with brain metastases. However, there is debate regarding its utility in patients with poor prognoses. In this study, we sought to characterize the use of WBRT in the United States, especially in adults aged 55 and above. Material and Methods: Patients with brain metastases were identified using the National Cancer Database between 2010 and 2013. The receipt and completion of WBRT with various patient factors were correlated using multivariable logistic regression. Results: 28,422 patients with brain metastases were identified, 23,362 of whom were aged 55 or above. 14,845 patients received WBRT and 12,310 patients completed treatment. Among adults aged 55 and above, 11,945 patients received WBRT, and 9812 patients completed treatment. Patients aged 60 and above were less likely to receive WBRT, while those aged 65 and above were less likely to complete WBRT. Discussion: These results suggest that WBRT may be over-utilized in the United States, especially among older adults. Better interventions to improve pre-WBRT decision-making in this population are needed to select patients who might derive benefit.
KW - Older adults
KW - Whole brain radiation therapy
UR - http://www.scopus.com/inward/record.url?scp=85082779039&partnerID=8YFLogxK
U2 - 10.1016/j.jgo.2020.03.010
DO - 10.1016/j.jgo.2020.03.010
M3 - Article
C2 - 32245729
AN - SCOPUS:85082779039
VL - 11
SP - 1096
EP - 1102
JO - Journal of Geriatric Oncology
JF - Journal of Geriatric Oncology
SN - 1879-4068
IS - 7
ER -